France: Eligo Bioscience expands investor syndicate
France-based Eligo Bioscience, a biotech company expanding the scope of gene-editing targets by focusing on the delivery of genetic medicines to the microbiome, has...
UK: THG raises £90m with founder and CEO contributing £60m
THG has raised £90m (US$116m) from new and existing shareholders, including a £60m contribution from the firm’s founder and CEO Matthew Moulding.
The equity contribution is comprised...
Switzerland: Healthcare Holding Schweiz accelerates growth in Medical Beauty
Healthcare Holding Schweiz, a Winterberg Group-backed buy, build & technologize platform and a leading provider of medical technology products and services in Switzerland, has...
Switzerland: Galderma rated BBB by S&P with positive outlook
Six-listed Galderma, a global pure-play manufacturer of dermatology products, has received a BBB long-term issuer credit rating with a positive outlook from S&P.
The rating...
Switzerland: Galderma announces plans to IPO on SIX Swiss Exchange
EQT-owned skin-care group, Galderma, has announced its intention to conduct an IPO on the SIX Swiss Exchange, marking the next step of Galderma’s growth...
Switzerland: Galderma places inaugural CHF500m two-tranche bond
Galderma, the SIX Swiss-listed pure play dermatology company, has placed an inaugural CHF500m (US$589m) two-tranche bond offering:
CHF250m four-year paying a 1.6% fixed-rate annual coupon
CHF250m...
Korea: Archimed takes Jeisys private to support non-invasive aesthetic international growth
Paris-based private equity firm, Archimed, has initiated the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices,...
Sweden: CVC completes sale of its remaining shares in Synsam for approximately SEK1.1bn
Theia Holdings, a company indirectly owned by CVC Capital Partners, has sold its remaining shareholding in Synsam, the Nordic region’s leading player in optical...
France: Archimed acquires majority stake in US-based Cellese
France-based global private equity healthcare specialist Archimed has acquired a majority stake in California-based Cellese, a developer of topical dermo cosmetics sold under the...
Switzerland: Exercise of over-allotment brings Galderma listing to CHF2.3bn
Galderma, the pure-play dermatology business that recently listed on the SIX Swiss exchange, has taken total size of the transaction to around CHF2.3bn (US$2.54bn)...
Advertisement
